The gene editing tool market is projected to grow from USD 814.7 million in 2025 to USD 4,410.8 million by 2035, at a CAGR of 18.4%. CRISPR/Cas9 will dominate with a 51.6% market share, while cell line engineering will lead the application segment with a 42.2% share.